ATE358477T1 - Oral anzuwendende arzneizusammensetzung enthaltend ein statinderivat - Google Patents

Oral anzuwendende arzneizusammensetzung enthaltend ein statinderivat

Info

Publication number
ATE358477T1
ATE358477T1 AT02727063T AT02727063T ATE358477T1 AT E358477 T1 ATE358477 T1 AT E358477T1 AT 02727063 T AT02727063 T AT 02727063T AT 02727063 T AT02727063 T AT 02727063T AT E358477 T1 ATE358477 T1 AT E358477T1
Authority
AT
Austria
Prior art keywords
composition containing
medicinal composition
statin derivative
oral medicinal
oral
Prior art date
Application number
AT02727063T
Other languages
English (en)
Inventor
Francis Vanderbist
Antonio Sereno
Philippe Baudier
Original Assignee
Galephar M F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galephar M F filed Critical Galephar M F
Application granted granted Critical
Publication of ATE358477T1 publication Critical patent/ATE358477T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02727063T 2001-06-12 2002-06-11 Oral anzuwendende arzneizusammensetzung enthaltend ein statinderivat ATE358477T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE200100098 2001-06-12

Publications (1)

Publication Number Publication Date
ATE358477T1 true ATE358477T1 (de) 2007-04-15

Family

ID=31501421

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02727063T ATE358477T1 (de) 2001-06-12 2002-06-11 Oral anzuwendende arzneizusammensetzung enthaltend ein statinderivat

Country Status (6)

Country Link
US (1) US20040235935A1 (de)
EP (1) EP1395254B1 (de)
AT (1) ATE358477T1 (de)
CA (1) CA2450238A1 (de)
DE (1) DE60219307T2 (de)
WO (1) WO2002100394A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006513186A (ja) * 2002-12-20 2006-04-20 ファイザー・プロダクツ・インク Ｃｅｔｐ阻害剤およびｈｍｇ−ｃｏａレダクターゼ阻害剤を含む剤形
WO2004056359A1 (en) * 2002-12-20 2004-07-08 Pfizer Products Inc. Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor
US20090042979A1 (en) * 2004-08-06 2009-02-12 Transform Pharmaceuticals Inc. Novel Statin Pharmaceutical Compositions and Related Methods of Treatment
JP2008509154A (ja) 2004-08-06 2008-03-27 トランスフオーム・フアーマシユーチカルズ・インコーポレーテツド 新規なスタチン薬剤組成物および関連治療方法
NZ552390A (en) * 2004-08-06 2010-01-29 Transform Pharmaceuticals Inc Novel fenofibrate formulations and related methods of treatment
CN101014254A (zh) * 2004-08-23 2007-08-08 荷兰联合利华有限公司 包含他汀的组合物
ES2255426B1 (es) * 2004-10-19 2007-08-16 Gp Pharm, S.A. Formulacion farmaceutica que comprende microcapsulas de estatinas suspendidas en ester alquilicos de acidos grasos poliinsaturados (pufa).
EP1818050A1 (de) * 2006-02-10 2007-08-15 Stada Arzneimittel Ag Stabile pharmazeutische Zusammensetzungen umfassend einen HMG-CoA-Reduktase Inhibitor
EP1825848A3 (de) * 2006-02-10 2010-03-03 Stada Arzneimittel Ag Stabile pharmazeutische Zusammensetzungen umfassend einen HMG-CoA-Reduktase Inhibitor
EP2081550B2 (de) 2006-03-09 2021-05-26 Reliant Pharmaceuticals, Inc. Beschichtung von kapseln mit pharmazeutischen wirkstoffen
US9597289B2 (en) 2006-04-26 2017-03-21 Rosemont Pharmaceuticals Ltd. Liquid oral simvastatin compositions
EP2220208A4 (de) * 2007-11-23 2010-12-29 Rappaport Family Inst For Res Verwendung von haptoglobingenotypisierung zur diagnose und behandlung von herz-kreislauf-erkrankungen
ITFI20080243A1 (it) * 2008-12-15 2010-06-16 Valpharma Sa Formulazioni per la somministrazione orale di acidi grassi omega polienoici in combinazione con statine di origine naturale o semi-sintetica.
CA2706270C (en) * 2010-06-03 2020-01-07 Accucaps Industries Limited Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation
WO2013090461A1 (en) * 2011-12-12 2013-06-20 PruGen IP Holdings, Inc. Statin bioavailability enhancement delivery composition
US9499621B2 (en) 2013-04-08 2016-11-22 Cytodyn, Inc. Felinized antibodies and methods of treating retroviral infections in felines
WO2015185240A1 (en) 2014-06-04 2015-12-10 Sigma-Tau Industrire Farmaceutiche Riunite S.P.A. Compositions containing simvastatin in omega-3 polyunsaturated fatty acids
US11369567B2 (en) 2016-06-08 2022-06-28 Liqmeds Worldwide Limited Aqueous suspension suitable for oral administration
GB201704687D0 (en) 2017-03-24 2017-05-10 Wockhardt Uk Ltd Pharmaceutical composition of simvastatin or salt thereof
WO2022129004A1 (en) 2020-12-15 2022-06-23 Dsm Ip Assets B.V. Coated statin tablet comprising vitamin e acetate powder
WO2022129002A1 (en) * 2020-12-15 2022-06-23 Dsm Ip Assets B.V. Coarse dispersion comprising statin and vitamin e oil

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
ATE429210T1 (de) * 1998-01-20 2009-05-15 Applied Analytical Ind Inc Orale flüssige zusammensetzungen
CA2348452A1 (en) * 1998-10-27 2000-05-04 Biovail Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
CA2352585A1 (en) * 1998-11-25 2000-06-02 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
JP2002532539A (ja) * 1998-12-18 2002-10-02 アボット・ラボラトリーズ 脂質調節剤を含む新規な製剤
CA2367995A1 (en) * 1999-03-31 2000-10-05 Abbott Laboratories Novel formulations comprising lipid-regulating agents
WO2000057859A1 (en) * 1999-03-31 2000-10-05 Abbott Laboratories Novel formulations comprising lipid-regulating agents
US6372251B2 (en) * 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents

Also Published As

Publication number Publication date
EP1395254B1 (de) 2007-04-04
CA2450238A1 (en) 2002-12-19
DE60219307D1 (de) 2007-05-16
DE60219307T2 (de) 2008-01-10
WO2002100394A1 (en) 2002-12-19
EP1395254A1 (de) 2004-03-10
US20040235935A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
ATE358477T1 (de) Oral anzuwendende arzneizusammensetzung enthaltend ein statinderivat
CL2009001682A1 (es) Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00).
ATE359077T1 (de) Orale gabe von 6-hydroxy-oxymorphon als analgetikum
NO20033343D0 (no) Farmasöytiske doseringsformer av epothiloner for oral administrasjon
EE200200357A (et) Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid
DE122011100049I1 (de) Stabile pharmazeutische Losungsformulierungen fur unter Druck stehende Inhaliergerate fur die Verabreichung abgemessener Dosen.
DE69115476D1 (de) Arzneimittel
ATE235897T1 (de) Arzneimittel in form parenenteral verabreichbarer lipidmikropartikel
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
ATE292453T1 (de) Antivirale arznei
DE60317803D1 (de) Pharmazeutische zusammensetzungen enthaltend cyclosporin zur oralen verabreichung
BR0314898A (pt) Compostos, composição cosmética, uso cosmético de uma composição, uso de um composto e composição farmacêutica
ATE367152T1 (de) Herstellungsverfahren für niedrig dosierte pharmazeutische zusammensetzung
MY129450A (en) Pharmaceutical composition
HUP0400115A2 (hu) Gyógyászati készítmény fulvesztrant intramuszkuláris beadására
DK1225902T3 (da) Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden
ATE337016T1 (de) Zusammensetzungen zur erhöhung der bioverfügbarkeit von oral verabreichten pharmazeutischen verbindungen
HUP0301082A2 (hu) Új polimorf olanzapine hidroklorid sók, eljárás ezek előállítására, az ezeket tartalmazó gyógyászati készítmények és felhasználásuk
NO20024108D0 (no) Oralt administrert kontrollert leveringssystem for þn daglig administrering av ciprofloxacin
NO20043007L (no) Farmasoytisk suspensjon for oral administrering
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin
FR2861992B1 (fr) Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide.
ITMI992736A0 (it) Composizioni farmaceutiche per la somministrazione localizzata nel cav o orale di farmaci antiinfiammatori non stereoidei utili per la terapi
DE60220953D1 (de) Pharmazeutische zusammensetzungen enthaltend eine antihistaminische abschwellende arzneistoffkombination und ein verfahren zur herstellung davon
NO20032581D0 (no) Farmasöytisk formulering av gepiron for oral administrering

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties